BACKGROUND: Immune signaling pathways influence neurodevelopment and are hypothesized to contribute to the etiology of autism spectrum disorder (ASD). We aimed to assess risk of ASD in relation to levels of neonatal acute phase proteins (APPs), key components of innate immune function, measured in neonatal dried blood spots.
METHODS: We included 924 ASD cases, 1092 unaffected population-based controls, and 203 unaffected siblings of ASD cases in this case-control study nested within the register-based Stockholm Youth Cohort. Concentrations of 9 different APPs were measured in eluates from neonatal dried blood spots from cases, controls, and siblings using a bead-based multiplex assay.
RESULTS: Neonatal C-reactive protein was consistently associated with odds of ASD in case-control comparisons, with higher odds associated with the highest quintile compared with the middle quintile (odds ratio [OR] = 1.50, 95% confidence interval [CI] = 1.10-2.04) in adjusted analyses. In contrast, the lowest quintiles of a-2-macroglobulin (OR = 3.71, CI = 1.21-11.33), ferritin (OR = 4.20, CI = 1.40-12.65), and serum amyloid P (OR = 3.05, CI = 1.16-8.01) were associated with odds of ASD in the matched sibling comparison. Neonatal APPs varied with perinatal environmental factors and maternal/fetal phenotypes. Significant interactions in terms of risk for ASD were observed between neonatal APPs and maternal infection during late pregnancy, maternal anemia, and maternal psychiatric history.
CONCLUSIONS: Indicators of the neonatal innate immune response are associated with risk of ASD, although the nature of these associations varies considerably with factors in the perinatal environment and the genetic background of the comparison group.
Neonatal Levels of Acute Phase Proteins and Risk of Autism Spectrum Disorder
Creators
Renee M. Gardner - Karolinska Institute
Brian K. Lee - Drexel University
Martin Brynge - Karolinska Institute
Hugo Sjoqvist - Karolinska Institute
Christina Dalman - Stockholm County Council
Hakan Karlsson - Karolinska Institute
Publication Details
Biological psychiatry (1969), v 89(5), pp 463-475
Publisher
Elsevier
Number of pages
13
Grant note
Stanley Medical Research Institute
7618 / Autism Speaks (Basic and Clinical Grant)
2016-01477; 2012-2264; 523-2010-1052 / Swedish Research Council; European Commission
Resource Type
Journal article
Language
English
Academic Unit
Epidemiology and Biostatistics
Web of Science ID
WOS:000615918300011
Scopus ID
2-s2.0-85096512401
Other Identifier
991019168591904721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: